Everyone who suffers from migraine headaches wants to know how to prevent their next migraine. Recent strong research has resulted in guidelines for doctors to help prevent their patients’ future migraines, including the use of herbs, vitamins and minerals. The guidelines make recommendations for specific types of patients, such as patients with certain other conditions, obese patients, new migraine patients, and pregnant/lactating women.
This research, conducted by the Canadian Headache Society, reviewed a large body of double-blind studies according to standardized criteria. They also did a general literature review and got expert consensus for aspects of prophylactic (preventative) migraine therapies that did not have randomized clinical trials.
Continue reading “Targeted Nutrients May Help Migraine Headaches”

As people age, eye diseases and conditions that commonly occur include macular degeneration, cataracts, vitreous tears/retinal tears and detachments, glaucoma, diabetic retinopathy, dry eyes, and eye floaters.
Drug maker GlaxoSmithKline has been found guilty of fraud in the way it reported research on, or marketed, on 3 of its medications in the largest settlement against a drug company in US history–$3 billion. The issues involved 10 drugs, and included marketing “off-label” use of the antidepressants Paxil and Wellbitrin and the asthma drug Advair, and not reporting all the safety data for the diabetes drug Avandia.
A pilot study published in Phytotherapy Research compared curcumin – derived from natural turmeric – with the drug diclofenac for treating rheumatoid arthritis (RA). Natural curcumin actually reduced RA symptoms even better than the RA drug diclofenac: a 44% reduction in symptoms on the Disease Activity Score and the American College of Rheumatology criteria for reduction of swelling and tenderness of joins. Patients receiving diclofenac had a 42% reduction.




